Literature DB >> 30407727

ETP-ALL with aberrant B marker expression: Case series and a brief review of literature.

Shikha Garg1, Sanjeev Kumar Gupta1, Sameer Bakhshi2, Saumyaranjan Mallick3, Lalit Kumar2.   

Abstract

Keywords:  ETP-ALL; aberrant markers in T-ALL; immunophenotyping in T-ALL

Mesh：

Substances：

Year:  2018        PMID： 30407727     DOI： 10.1111/ijlh.12942

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  4 in total

1.  In Silico Integration of Transcriptome and Interactome Predicts an ETP-ALL-Specific Transcriptional Footprint that Decodes its Developmental Propensity.

Authors:  Soumyadeep Mukherjee; Arpita Kar; Paramita Paul; Souvik Dey; Avik Biswas; Subhasis Barik
Journal:  Front Cell Dev Biol       Date:  2022-05-13

Review 2.  Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick.

Authors:  Francesco Tarantini; Cosimo Cumbo; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Biomark Res       Date:  2021-12-20

3.  MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus.

Authors:  Kirsten Canté-Barrett; Mariska T Meijer; Valentina Cordo'; Rico Hagelaar; Wentao Yang; Jiyang Yu; Willem K Smits; Marloes E Nulle; Joris P Jansen; Rob Pieters; Jun J Yang; Jody J Haigh; Steven Goossens; Jules Pp Meijerink
Journal:  JCI Insight       Date:  2022-07-08

4.  Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Parathan Karunakaran; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Blood Res       Date:  2022-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.